TOI CFO Mihir Shah resigns; Rob Carter promoted to CFO effective Oct 14

Oncology Institute, Inc.

CFO Mihir Shah resigns effective October 14, 2024, to pursue other opportunities; departure not related to operations or accounting policies.
Rob Carter, SVP of Finance since December 2021, promoted to CFO effective October 14, 2024; will serve as principal financial and accounting officer.
Carter brings over a decade of healthcare finance leadership, including roles at Hoag Health System, Kaiser Permanente, SCAN Health Plan, and McKesson.
Carter's initial base salary is $375,000 with a 40% target bonus; equity award to be granted on next regular quarterly grant date.
Shah will assist transition as an advisor under a consulting arrangement at an agreed hourly rate.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert Carter

Chief Financial Officer

TOI · Oncology Institute, Inc.

Effective: 2024-10-14
Filed: September 23, 2024, 7:59 PM ET

On September 20, 2024, the Company appointed Robert Carter to replace Mr. Shah as the Company’s Chief Financial Officer, with effect on October 14, 2024.

Departed

Mihir Shah

Chief Financial Officer

TOI · Oncology Institute, Inc.

Effective: 2024-10-14
Successor: Robert Carter
Filed: September 23, 2024, 7:59 PM ET

On September 19, 2024, Mihir Shah, the Chief Financial Officer, principal financial officer, and principal accounting officer of The Oncology Institute, Inc. (the “Company”), delivered a notice of resignation effective as of October 14, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Carter was appointed as Chief Financial Officer at Oncology Institute, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On September 20, 2024, the Company appointed Robert Carter to replace Mr. Shah as the Company’s Chief Financial Officer, with effect on October 14, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mihir Shah resigned as Chief Financial Officer at Oncology Institute, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On September 19, 2024, Mihir Shah, the Chief Financial Officer, principal financial officer, and principal accounting officer of The Oncology Institute, Inc. (the “Company”), delivered a notice of resignation effective as of October 14, 2024.

View on SEC.gov

Oncology Institute, Inc. filing history →

Source: SEC EDGAR

accession 0001553350-24-000088

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.